Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ELK1 pseudogene 1 (ELK1P1) is a processed pseudogene derived from the ELK1 gene, part of the ETS transcription factor family. Unlike the functional ELK1 gene, which plays a regulatory role in gene expression through binding serum response elements in association with SRF and is involved in cellular processes such as proliferation, apoptosis, and neuronal function, ELK1P1 does not code for a functional protein and is generally regarded as nonfunctional. Pseudogenes like ELK1P1 arise by the duplication or retrotransposition of a functional gene but accumulate mutations or truncations that render them incapable of encoding the corresponding protein. There is no evidence supporting ELK1P1 as a therapeutic target, disease gene, or functional regulatory element.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ELK1 pseudogene 1 (ELK1P1).